Lg Life Sciences, Limited

Invitros Co., Ltd.

Hoon Sung Jeh

Suk Young Choi

Myung Jin Kim

Seung Joo Lee

Jae Hoon Oh

Se Ryun Kim

Ji Eon Kim

Chang Ju Park

Jin-Seok Oh

Sang Hun Lee

Kyu Chan Kwon

Young Cheol Kang

Jin-Seok c/o Lg Life Sciences Ltd Oh

Ji Eon c/o Lg Life Sciences Ltd Kim

A gene amplification module is disclosed. According to one aspect of the present invention, provided is a gene amplification module including: a heat block in which a reaction container accommodation space is defined; a heating part provided below the heat block; a cooling part provided below the heating part; and a fluid supply part provided to face one side of the heat block, the fluid supply part being configured to supply a cooling fluid to the heat block, wherein sidewalls defining a circumference of the heat block are provided on the heat block, and one or more supply holes configured to supply the cooling fluid are defined in the sidewalls.

Gene amplification module

The present invention provides an aqueous formulation of human erythropoietin having the storage stability over a long period without serum albumin, in which the formulation comprises a pharmaceutically effective amount of human erythropoietin; non-ionic surfactant, polyhydric alcohol, neutral amino acid and sugar alcohol as stabilizers; isotonic reagent; and buffering reagent.

Stable, aqueous solution of human erythropoietin, not containing serum albumin

Disclosed is a sustained release composition of a protein drug. The composition comprises a carrier substrate and a protein drug incorporated in the carrier substrate. The carrier substrate is consisting essentially of a hyaluronic acid or its salts, an amino acid, and a polyalkyl oxide.

Sustained release composition of protein drug

Growing community of inventors

Daejeon, South Korea

Hoon Sung Jeh